A16z Perennial Management, L.P. Astrazeneca PLC Transaction History
A16z Perennial Management, L.P.
- $1.31 Trillion
- Q3 2025
A detailed history of A16z Perennial Management, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, A16z Perennial Management, L.P. holds 3,986 shares of AZN stock, worth $333,907. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,986Holding current value
$333,907% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,458Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...